Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. Social Networks
  11. External Links
  12. Analytics And Tracking
  13. Libraries
  14. Hosting Providers
  15. CDN Services

We began analyzing https://eurjmedres.biomedcentral.com/articles/10.1186/s40001-022-00863-0, but it redirected us to https://eurjmedres.biomedcentral.com/articles/10.1186/s40001-022-00863-0. The analysis below is for the second page.

Title[redir]:
Bile pigments in emergency and critical care medicine | European Journal of Medical Research | Full Text
Description:
Bile pigments, such as bilirubin and biliverdin, are end products of the heme degradation pathway in mammals and are widely known for their cytotoxic effects. However, recent studies have revealed that they exert cytoprotective effects through antioxidative, anti-inflammatory, and immunosuppressive properties. All these mechanisms are indispensable in the treatment of diseases in the field of emergency and critical care medicine, such as coronary ischemia, stroke, encephalomyelitis, acute lung injury/acute respiratory distress syndrome, mesenteric ischemia, and sepsis. While further research is required before the safe application of bile pigments in the clinical setting, their underlying mechanisms shed light on their utilization as therapeutic agents in the field of emergency and critical care medicine. This article aims to summarize the current understanding of bile pigments and re-evaluate their therapeutic potential in the diseases listed above.

Matching Content Categories {πŸ“š}

  • Science
  • Health & Fitness
  • Education

Content Management System {πŸ“}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of doi.org audience?

πŸ™οΈ Massive Traffic: 50M - 100M visitors per month


Based on our best estimate, this website will receive around 75,529,999 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {πŸ’Έ}

We're unsure if the website is profiting.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Doi.org could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {πŸ”}

pubmed, article, google, scholar, cas, bile, pigments, bilirubin, effects, cell, cells, ros, biliverdin, heme, administration, injury, central, medicine, lung, critical, diseases, therapeutic, oxidative, antioxidant, rats, care, treatment, encephalomyelitis, clinical, showed, inflammatory, emergency, pathway, antiinflammatory, levels, disease, studies, mechanisms, damage, apoptosis, cardiac, ischemia, demonstrated, role, reduced, fig, study, expression, transplantation, graft,

Topics {βœ’οΈ}

bleomycin-induced lung damage uridine-diphosphoglucuronic glucuronosyltransferase conjugates additional information publisher' anti-4-hne antibody-positive cells xenobiotic-induced murine model pre-bv-treated specimens 24 lps-induced neutrophil infiltration weakens ho-1-mediated antioxidant reactive oxygen species stopped sepsis-induced ileus anti-inflammation therapy alter nf-ΞΊb activation oxidative stress-induced damage acute rejection reduction cardiac ischemia/reperfusion injury transcription factor nf-kappa bv-treated intestinal grafts critical care medicine improving long-term outcomes accentuated clp-induced increase diminished anti-inflammatory pathways scavenging phagocytosis-induced ros lps-induced endotoxemia [55] author information authors anti-donor alloantibodies 60Β days privacy choices/manage cookies br-bv redox cycle tumor necrosis factor human myocardial ischemia bmc bilirubin/biliverdin therapeutic application 8-hydroxy-2β€²-deoxyguanosine ali/ards account european journal anti-inflammatory mediators ho-1 ischemia/reperfusion injury ischemia-reperfusion injury reduced neutrophil migration induced pulmonary fibrosis lung endothelial cells br-administered blm groups immune-mediated encephalomyelitis european economic area graft post-transplantation experimental autoimmune encephalomyelitis vascular endothelial injury biliverdin administration prevents bronchoalveolar lavage fluid proofreading sections 2047-783x contact monocyte chemoattractant protein

Questions {❓}

  • What is nuclear factor kappa B (NF-kappaB) doing in and to the mitochondrion?

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Bile pigments in emergency and critical care medicine
         description:Bile pigments, such as bilirubin and biliverdin, are end products of the heme degradation pathway in mammals and are widely known for their cytotoxic effects. However, recent studies have revealed that they exert cytoprotective effects through antioxidative, anti-inflammatory, and immunosuppressive properties. All these mechanisms are indispensable in the treatment of diseases in the field of emergency and critical care medicine, such as coronary ischemia, stroke, encephalomyelitis, acute lung injury/acute respiratory distress syndrome, mesenteric ischemia, and sepsis. While further research is required before the safe application of bile pigments in the clinical setting, their underlying mechanisms shed light on their utilization as therapeutic agents in the field of emergency and critical care medicine. This article aims to summarize the current understanding of bile pigments and re-evaluate their therapeutic potential in the diseases listed above.
         datePublished:2022-10-29T00:00:00Z
         dateModified:2022-10-29T00:00:00Z
         pageStart:1
         pageEnd:11
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s40001-022-00863-0
         keywords:
            Bile pigments
            Emergency and critical care medicine
            Antioxidant therapy
            Medicine/Public Health
            general
            Infectious Diseases
            Internal Medicine
            Surgery
            Oncology
            Biomedicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-022-00863-0/MediaObjects/40001_2022_863_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-022-00863-0/MediaObjects/40001_2022_863_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-022-00863-0/MediaObjects/40001_2022_863_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-022-00863-0/MediaObjects/40001_2022_863_Fig4_HTML.png
         isPartOf:
            name:European Journal of Medical Research
            issn:
               2047-783X
            volumeNumber:27
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Mizuki Seya
               affiliation:
                     name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
                     address:
                        name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Toshiyuki Aokage
               affiliation:
                     name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
                     address:
                        name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Tsuyoshi Nojima
               affiliation:
                     name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
                     address:
                        name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Atsunori Nakao
               affiliation:
                     name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
                     address:
                        name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hiromichi Naito
               affiliation:
                     name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
                     address:
                        name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Bile pigments in emergency and critical care medicine
      description:Bile pigments, such as bilirubin and biliverdin, are end products of the heme degradation pathway in mammals and are widely known for their cytotoxic effects. However, recent studies have revealed that they exert cytoprotective effects through antioxidative, anti-inflammatory, and immunosuppressive properties. All these mechanisms are indispensable in the treatment of diseases in the field of emergency and critical care medicine, such as coronary ischemia, stroke, encephalomyelitis, acute lung injury/acute respiratory distress syndrome, mesenteric ischemia, and sepsis. While further research is required before the safe application of bile pigments in the clinical setting, their underlying mechanisms shed light on their utilization as therapeutic agents in the field of emergency and critical care medicine. This article aims to summarize the current understanding of bile pigments and re-evaluate their therapeutic potential in the diseases listed above.
      datePublished:2022-10-29T00:00:00Z
      dateModified:2022-10-29T00:00:00Z
      pageStart:1
      pageEnd:11
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s40001-022-00863-0
      keywords:
         Bile pigments
         Emergency and critical care medicine
         Antioxidant therapy
         Medicine/Public Health
         general
         Infectious Diseases
         Internal Medicine
         Surgery
         Oncology
         Biomedicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-022-00863-0/MediaObjects/40001_2022_863_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-022-00863-0/MediaObjects/40001_2022_863_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-022-00863-0/MediaObjects/40001_2022_863_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-022-00863-0/MediaObjects/40001_2022_863_Fig4_HTML.png
      isPartOf:
         name:European Journal of Medical Research
         issn:
            2047-783X
         volumeNumber:27
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Mizuki Seya
            affiliation:
                  name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
                  address:
                     name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Toshiyuki Aokage
            affiliation:
                  name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
                  address:
                     name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Tsuyoshi Nojima
            affiliation:
                  name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
                  address:
                     name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Atsunori Nakao
            affiliation:
                  name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
                  address:
                     name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hiromichi Naito
            affiliation:
                  name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
                  address:
                     name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:European Journal of Medical Research
      issn:
         2047-783X
      volumeNumber:27
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
      address:
         name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
         type:PostalAddress
      name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
      address:
         name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
         type:PostalAddress
      name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
      address:
         name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
         type:PostalAddress
      name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
      address:
         name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
         type:PostalAddress
      name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
      address:
         name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Mizuki Seya
      affiliation:
            name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
            address:
               name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
               type:PostalAddress
            type:Organization
      name:Toshiyuki Aokage
      affiliation:
            name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
            address:
               name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Tsuyoshi Nojima
      affiliation:
            name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
            address:
               name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
               type:PostalAddress
            type:Organization
      name:Atsunori Nakao
      affiliation:
            name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
            address:
               name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
               type:PostalAddress
            type:Organization
      name:Hiromichi Naito
      affiliation:
            name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
            address:
               name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
      name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
      name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
      name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
      name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan

External Links {πŸ”—}(397)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Prism.js

Emails and Hosting {βœ‰οΈ}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {πŸ“¦}

  • Crossref

4.35s.